Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.4270C>G | p.Pro1424Ala | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
CCA | Pro | GCA | Ala | C->G | Tv |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
cb EGF-like #20 | Ca2+ binding | Yes, coding strand | No |
At the mRNA level | On restriction map |
NA | New restriction site(s): none Lost restriction site(s): none |
Conservation (0-1) | SIFT (0-1) | UMD-predictor (0-100) |
---|---|---|
1 | 0.25 (non pathogenous) | 71 (Probably pathogenous) |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
UKD05LON F0152 I01 | Proband | NA | NA | U.K. |
Phenotypic group | Disease |
NA | Incomplete MFS |
Symptom | Age |
C-Dilation or dissection of asc. aorta | 47 |
Reference ID | PubMed ID | Reference |
96 | 17657824 | Comeglio P, Johnson P, Arno G, Brice G, Evans A, Aragon-Martin J, da Silva FP, Kiotsekoglou A, Child A. "The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutations". Hum Mutat. 2007 Sep;28(9):928. |